Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT

Bone Marrow Transplantation

Volumn 46, Issue 6, 2011, Pages 863-869

  Ishiyama, K ^a   Katagiri, T ^a   Hoshino, T ^b   Yoshida, T ^c   Yamaguchi, M ^d   Nakao, S ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^c TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

alternative donors; foscarnet sodium; hematopoietic stem cell transplantation; human herpesvirus 6; limbic encephalitis

Indexed keywords

CYCLOSPORIN A; FOSCARNET SODIUM; HYDROCORTISONE SODIUM SUCCINATE; TACROLIMUS; VIRUS DNA;

ADULT; AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DNA DETERMINATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; FEMALE; GENE DOSAGE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6 ENCEPHALITIS; HYPERNATREMIA; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MALE; MULTICENTER STUDY; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; VIREMIA; VIRUS ENCEPHALITIS; VIRUS LOAD;

ADOLESCENT; ADULT; CHEMOPREVENTION; DNA, VIRAL; ENCEPHALITIS; FEMALE; FOSCARNET; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MIDDLE AGED; PREMEDICATION; ROSEOLOVIRUS INFECTIONS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958132650     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.201     Document Type: Article

References (38)

1. Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846-1854. (Pubitemid 30419048)
2. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962-2971.
3. Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257-260. (Pubitemid 34619076)
4. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood 2003; 101: 4233-4244.
5. Moretta A, Maccario R, Fagioli F, Giraldi E, Busca A, Montagna D et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29: 371-379. (Pubitemid 32220129)
6. Niehues T, Rocha V, Filipovich AH, Chan KW, Porcher R, Michel G et al. Factors affecting lymphocyte subset reconstitution after either related or unrelated cord blood transplantation in children - a Eurocord analysis. Br J Haematol 2001; 114: 42-48. (Pubitemid 32702631)
7. Locatelli F, Maccario R, Comoli P, Bertolini F, Giorgiani G, Montagna D et al. Hematopoietic and immune recovery after transplantation of cord blood progenitor cells in children. Bone Marrow Transplant 1996; 18: 1095-1101. (Pubitemid 27026265)
8. Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96: 2703-2711.
9. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275. (Pubitemid 39552742)
10. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276-2285. (Pubitemid 39552743)
11. Yoshikawa T, Ihira M, Ohashi M, Suga S, Asano Y, Miyazaki H et al. Correlation between HHV-6 infection and skin rash after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 28: 77-81. (Pubitemid 32707621)
12. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Sobue R et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991; 78: 1381-1384.
13. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med 1994; 330: 1356-1360. (Pubitemid 24136059)
14. Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 932-940. (Pubitemid 40418297)
15. Noguchi T, Mihara F, Yoshiura T, Togao O, Atsumi K, Matsuura T et al. MR imaging of human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation in adults. AJNR Am J Neuroradiol 2006; 27: 2191-2195. (Pubitemid 44788653)
16. Zerr DM, Gupta D, Huang ML, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 309-317. (Pubitemid 34062230)
17. Fujimaki K, Mori T, Kida A, Tanaka M, Kawai N, Matsushima T et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006; 84: 432-437. (Pubitemid 46052633)
18. Huang LM, Kuo PF, Lee CY, Chen JY, Liu MY, Yang CS. Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma. J Med Virol 1992; 38: 7-10.
19. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995; 171: 273-280.
20. Chan PK, Peiris JS, Yuen KY, Liang RH, Lau YL, Chen FE et al. Human herpesvirus-6 and human herpesvirus-7 infections in bone marrow transplant recipients. J Med Virol 1997; 53: 295-305. (Pubitemid 28201842)
21. Imbert-Marcille BM, Tang XW, Lepelletier D, Besse B, Moreau P, Billaudel S et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000; 31: 881-886. (Pubitemid 32299342)
22. Wang FZ, Dahl H, Linde A, Brytting M, Ehrnst A, Ljungman P. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88: 3615-3620. (Pubitemid 26365600)
23. Wang H, Zhu L, Xue M, Liu J, Guo Z. Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation. Biol Blood Marrow Transplant 2009; 15: 519-520.
24. Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006; 193: 68-79. (Pubitemid 43032501)
25. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37: 132-136. (Pubitemid 29004193)
26. Tanaka N, Kimura H, Hoshino Y, Kato K, Yoshikawa T, Asano Y et al. Monitoring four herpesviruses in unrelated cord blood transplantation. Bone Marrow Transplant 2000; 26: 1193-1197.
27. Yoshihara S, Kato R, Inoue T, Miyagawa H, Sashihara J, Kawakami M et al. Successful treatment of life-threatening human herpesvirus-6 encephalitis with donor lymphocyte infusion in a patient who had undergone human leukocyte antigen-haploidentical nonmyeloablative stem cell transplantation. Transplantation 2004; 77: 835-838. (Pubitemid 38436819)
28. Wang FZ, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999; 28: 562-568.
29. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124: 1065-1071.
30. Narimatsu H, Kami M, Kato D, Matsumura T, Murashige N, Kusumi E et al. Reduced dose of foscarnet as preemptive therapy for cytomegalovirus infection following reduced-intensity cord blood transplantation. Transpl Infect Dis 2007; 9: 11-15.
31. Le Cleach L, Joberty C, Fillet AM, Sutton L, Cordonnier C, Frances C et al. Human herpesvirus 6 infection in patients with exanthema after allogeneic bone marrow transplantation. Arch Dermatol 1998; 134: 759-760. (Pubitemid 28283736)
32. Cone RW, Huang ML, Corey L, Zeh J, Ashley R, Bowden R. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 1999; 179: 311-318. (Pubitemid 29086631)
33. Volin L, Lautenschlager I, Juvonen E, Nihtinen A, Anttila VJ, Ruutu T. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 2004; 126: 690-696. (Pubitemid 39221305)
34. Yamane A, Mori T, Suzuki S, Mihara A, Yamazaki R, Aisa Y et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007; 13: 100-106. (Pubitemid 46044094)
35. Hentrich M, Oruzio D, Jager G, Schlemmer M, Schleuning M, Schiel X et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005; 128: 66-72.
36. Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002; 100: 2005-2011. (Pubitemid 35001230)
37. Rapaport D, Engelhard D, Tagger G, Or R, Frenkel N. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis 2002; 4: 10-16. (Pubitemid 34786820)
38. Tokimasa S, Hara J, Osugi Y, Ohta H, Matsuda Y, Fujisaki H et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29: 595-598. (Pubitemid 34537720)